Youtube - PAREXEL Insights

This Stream includes all Videos from our PAREXEL Insights Youtube playlist

  • PAREXEL - Josh Schultz, Corp. VP Talks About PAREXEL Access1:20

    PAREXEL - Josh Schultz, Corp. VP Talks About PAREXEL Access

    Our industry is undergoing a profound shift, from a world where achieving marketing authorization approval was sufficient to both get access to patients and to get reimbursed at appropriate level. Ho

    Watch Video
  • PAREXEL - Shogo Nakamori Discusses PAREXEL's High Performance Culture2:28

    PAREXEL - Shogo Nakamori Discusses PAREXEL's High Performance Culture

    Japan is the second largest pharmaceutical market and success in Japan is mandatory for pharmaceutical companies. Japan’s health authority requests data in the Japanese population; therefore, a certai

    Watch Video
  • PAREXEL - Shogo Nakamori Discusses Trends in Drug Development in Japan5:12

    PAREXEL - Shogo Nakamori Discusses Trends in Drug Development in Japan

    When I look at recent trends in drug development in Japan, the following seven points are very important. First, Japan Pharmaceutical and Medical Device Act (JPMD-Act) was renewed in November 2014. T

    Watch Video
  • PAREXEL - Albert Liou Discusses the Drug Development Landscape in Korea1:59

    PAREXEL - Albert Liou Discusses the Drug Development Landscape in Korea

    Korea is becoming a global hub for many reasons. There is a good infrastructure, good regulatory system, and there also there are a lot of professionals with good talent in this country. Since 2000’s

    Watch Video
  • PAREXEL - Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies3:51

    PAREXEL - Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies

    PAREXEL helps position emerging Biopharmaceutical companies by providing them with advice and capabilities. We provide them with advice regarding clinical research strategies, regulatory strategies,

    Watch Video
  • PAREXEL - Mark A. Goldberg, Pres. & COO, Discusses PAREXEL’s Acquisition of Quantum Solutions India2:08

    PAREXEL - Mark A. Goldberg, Pres. & COO, Discusses PAREXEL’s Acquisition of Quantum Solutions India

    I think the QSI acquisition is going to help benefit our clients. First of all, this is an up and running company with significant scale. They already serve some of the world’s largest pharmaceutical

    Watch Video
  • PAREXEL - Albert Sui, PhD, Explains How PAREXEL Academy Benefits Clients0:55

    PAREXEL - Albert Sui, PhD, Explains How PAREXEL Academy Benefits Clients

    PAREXEL Academy has many programs, but I’d like to talk about one in particular directly helping us to address our clients’ needs. It is in training our clinical monitors or training the external stud

    Watch Video
  • PAREXEL - Ubavka DeNoble Talks About PAREXEL's BioPharm Unit2:15

    PAREXEL - Ubavka DeNoble Talks About PAREXEL's BioPharm Unit

    The BioPharm unit is actually a business unit that is fully dedicated to collaboration with small to medium size companies. Our main objective is to execute and deliver clinical trial programs and pul

    Watch Video
  • PAREXEL - Albert Sui, VP Explains PAREXEL's Training Approach0:46

    PAREXEL - Albert Sui, VP Explains PAREXEL's Training Approach

    At PAREXEL, our training approach is really first having a really good design for our program. In this design, we always use real life situations as people encounter at work so that people get a chanc

    Watch Video
  • PAREXEL - Sy Pretorius, M.D., Chief Scientific Officer talks about Adaptive Designs10:31

    PAREXEL - Sy Pretorius, M.D., Chief Scientific Officer talks about Adaptive Designs

    Today, we see more and more clinical trials with adaptive design protocols. Part of my job is to evaluate a need and determine the advantages and benefits for implementing an adaptive design for our

    Watch Video
  • PAREXEL - Dr Sy Pretorius, Chief Scientific Officer on Protocol Optimization5:42

    PAREXEL - Dr Sy Pretorius, Chief Scientific Officer on Protocol Optimization

    At PAREXEL, we frequently get asked questions about protocol optimization – what it is, how it works, and trends in protocol design and optimization. Protocol optimization is a service that we at PAR

    Watch Video
  • PAREXEL - Why Join PAREXEL?  Albert Sui PhD VP of Training Explains0:51

    PAREXEL - Why Join PAREXEL? Albert Sui PhD VP of Training Explains

    PAREXEL has an organization called PAREXEL Academy that is dedicated to developing our employees. The people that come through the PAREXEL Academy programs learn very useful skills to help in their jo

    Watch Video
  • loading
    Loading More...